[Recent therapeutic strategies and new drugs].
Recent therapeutic strategies are presenting concerning the use of morphine, benzodiazepines, hypoglycemic agents, glucocorticoids and several specific treatments are indicated. Three new molecules deserve special attention: tiotropium, fondaparinux and omalizumab.
Sternon
J
J
Hôpital Erasme et C.U.M.G.-U.L.B.
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D004358:Drug Therapy / Q000379:methods* / Q000639:trends*; D005170:Factor X / Q000037:antagonists & inhibitors; D000077425:Fondaparinux; D006801:Humans; D000069444:Omalizumab; D010276:Parasympatholytics / Q000627:therapeutic use; D011134:Polysaccharides / Q000627:therapeutic use; D012602:Scopolamine Derivatives / Q000627:therapeutic use; D000069447:Tiotropium Bromide
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D010276:Parasympatholytics; D011134:Polysaccharides; D012602:Scopolamine Derivatives; D000069444:Omalizumab; D005170:Factor X; D000077425:Fondaparinux; D000069447:Tiotropium Bromide